99 related articles for article (PubMed ID: 511604)
1. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
Heldman DA; Grever MR; Speicher CE; Trewyn RW
J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
[TBL] [Abstract][Full Text] [Related]
3. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
4. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
Tormey DC; Waalkes TP; Gehrke CW
J Surg Oncol; 1980; 14(3):267-73. PubMed ID: 7392649
[TBL] [Abstract][Full Text] [Related]
5. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
[TBL] [Abstract][Full Text] [Related]
6. Biochemically detectable tumor markers in urine of bladder cancer patients.
Irving CC
Cancer Res; 1977 Aug; 37(8 Pt 2):2872-4. PubMed ID: 872116
[TBL] [Abstract][Full Text] [Related]
7. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
Heldman DA; Grever MR; Miser JS; Trewyn RW
J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
[TBL] [Abstract][Full Text] [Related]
8. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine.
Waalkes TP; Dinsmore SR; Mrochek JE
J Natl Cancer Inst; 1973 Jul; 51(1):271-4. PubMed ID: 4720877
[No Abstract] [Full Text] [Related]
10. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
[TBL] [Abstract][Full Text] [Related]
11. Differential excretion of modified nucleosides in adult acute leukemia.
Heldman DA; Grever MR; Trewyn RW
Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
[TBL] [Abstract][Full Text] [Related]
12. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process.
Tebib JG; Reynaud C; Cedoz JP; Letroublon MC; Niveleau A
Br J Rheumatol; 1997 Sep; 36(9):990-5. PubMed ID: 9376997
[TBL] [Abstract][Full Text] [Related]
13. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
Nyholm KK; Sjolin KE; Wolf H; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of urinary nucleosides by high-performance liquid chromatography.
Liebich HM; Di Stefano C; Wixforth A; Schmid HR
J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
Cho SH; Choi MH; Lee WY; Chung BC
Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175
[TBL] [Abstract][Full Text] [Related]
17. [Excretion of methylated nucleosides in the initial therapy phase in a case of anorexia nervosa].
Clemens P; Schöch G; Ziemer G; Altenhoff J; Erb N; Lorenz H; Müller J; Grüttner R
Padiatr Padol; 1982; 17(2):157-63. PubMed ID: 7099674
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids.
Davis GE; Suits RD; Kuo KC; Gehrke CW; Waalkes TP; Borek E
Clin Chem; 1977 Aug; 23(8):1427-35. PubMed ID: 872405
[No Abstract] [Full Text] [Related]
19. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle.
Lehtiö H; Mäenpää PH
Clin Chim Acta; 1977 Oct; 80(1):181-5. PubMed ID: 908140
[TBL] [Abstract][Full Text] [Related]
20. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
Kvist E; Sjølin KE
Scand J Urol Nephrol; 1990; 24(4):283-5. PubMed ID: 2274752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
